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Objectives. We examined the prognostic significance ofconcen- 
tric remodeling of the left ventricle in patients with essential 
hypertension and normal eft ventricular mass on echocardiogra- 
phy. 
Background. An echocardiographic pattern of concentric re- 
modeling of the left ventricle has been associated with clinical 
features of increased cardiovascular risk, but the independent 
prognostic value of this finding in hypertensive patients with 
normal eft ventricular mass has not been established. 
Methods. Six hundred ninety-four patients with essential hyper- 
tension and normal left ventricular mass (< 125 g/m 2) on echocardi- 
ography were prospectively followed up for <7.7 years (mean 2.71). 
Baseline chocardiography and 24-h noninvasive ambulatory blood 
pressure monitoring were performed in all patients at the time of 
initial diagnostic evaluation. Concentric remodeling was defined by 
the thickness of the septum or posterior wall divided by the left 
ventricular radius at end-diastole ->0.45. 
Results. Prevalence of concentric remodeling was 39.2%. Dur- 
ing follow-up there were 29 cardiovascular morbid events. Car- 
diovascular morbidity, expressed as the combined number of fatal 
and nonfatal events per 100 patient-years, was 1.53 in the overall 
study group, 1.12 in the subgroup with normal eft ventricular 
geometry and 2.39 in that with concentric remodeling. After 
assessment ofthe independent association with several covariates 
(age, gender, diabetes, left ventricular mass index, mean clinic 
blood pressure and mean 24-h ambulatory blood pressure) in Cox 
proportional hazard models, the risk of cardiovascular morbid 
events was higher in the group with concentric remodeling than in 
that with normal geometry. (relative risk 2.56, 95% confidence 
interval 1.20 to 5.45, p < 0.01). 
Conclusions. Concentric remodeling of the left ventricle, de- 
fined by the thickness of the septum or posterior wall divided by 
the left ventricular radius at end-diastole >0.45, is an important 
and independent predictor of increased cardiovascular risk in 
hypertensive patients with normal eft ventricular mass on echo- 
cardiography. 
(J Am Coil Cardiol 1995;25:871-8) 
In essential hypertension, the risk of future cardiovascular 
complications is greater in patients with left ventricular hyper- 
trophy at echocardiography than in those with normal left 
ventricular mass (1,2). The direct association over a wide range 
between left ventricular mass and incidence of cardiovascular 
morbid events (3,4) suggests that even subtle changes in 
ventricular mass within the normal range might be predictive 
of increased cardiovascular risk. In this setting, some observa- 
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tions suggest that a more complete definition of left ventricular 
geometry might be a promising approach to improve cardio- 
vascular isk stratification in hypertension. In a long-term 
prospective study in hypertensive patients, Koren at al. (2) 
found that the risk of cardiovascular morbid events in subjects 
with left ventricular concentric remodeling (i.e., echocardio- 
graphic left ventricular mass <125 g/m 2 and thickness of the 
posterior wall divided by the left ventricular radius at end- 
diastole ->0.45) was intermediate between those with normal 
left ventricular mass and geometry and those with ventricular 
mass >125 g/m 2. Prevalence of left ventricular remodeling in 
hypertensive subjects with normal ventricular mass ranged 
between 16% (5) and 19% (6) in clinical studies where 
remodeling was defined solely by the relative thickening of the 
posterior wall but increased to up to 39% when the definition 
also included isolated thickening of the interventricular sep- 
turn (6). 
The present study was conducted in patients with essential 
hypertension a d normal eft ventricular mass at echocardiog- 
raphy at the time of their initial diagnostic studies in the 
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absence of therapy. Subjects were obtained from the PIUMA 
database (Progetto Ipertensione Umbria Monitoraggio Ambu- 
latoriale), an observational registry of morbidity and mortality 
in hypertensive subjects whose initial evaluation included 
noninvasive ambulatory blood pressure monitoring according 
to a standardized protocol (6,7). We compared the outcome of 
patients with normal left ventricular geometry with that of 
patients with concentric left ventricular remodeling in terms 
of cardiovascular morbid event rate over the subsequent years. 
Methods 
Study patients. The study group was composed of 694 
consecutive hypertensive subjects included in the PIUMA 
registry (6) up to July 1993 who fulfilled the two admission 
criteria of good quality echocardiographic tracings and normal 
left ventricular mass (see later). Hypertensive subjects were 
identified in a prevalently rural area by a group of general 
practitioners who referred all patients with high blood pressure 
to our centers. Excluded from the present study, although 
included in the PIUMA registry over the same period, were 
240 patients with left ventricular mass ->125 g/m 2, 253 patients 
with echocardiographic tracings of inadequate quality to de- 
termine ventricular mass and 109 patients who did not perform 
the echocardiographic study for administrative r asons. 
Admission criteria to the PIUMA registry included all of the 
following: 1) essential hypertension with sitting blood pressure 
->140 mm Hg systolic or 90 mm Hg diastolic on at least hree 
visits in the last 3 weeks; 2) any previous antihypertensive drugs 
withdrawn for ->4 weeks; 3) agreement within 5 mm Hg 
between mercury column and automatic recorder in at least 
three consecutive measurements taken simultaneously on the 
same arm before beginning ambulatory blood pressure moni- 
toring; 4) at least one valid ambulatory blood pressure reading/ 
hr; 5) absence of heart failure, valvular defects or concomitant 
important disease. The initial evaluation of all these subjects 
included adetailed medical history, 12-lead electrocardiogram 
(ECG), funduscopic evaluation, screening laboratory tests 
(urinalysis and determination f serum levels of urea nitrogen, 
creatinine, glucose, uric acid, cholesterol, sodium, potassium 
and calcium) and a routine standard and Doppler echocardio- 
graphic study from October 1987. Diabetes mellitus was de- 
fined by any one of the following: a fasting blood glucose level 
>140 mg/dl, a random nonfasting blood glucose level >200 
mg/dl or the use of an oral hypoglycemic agent or insulin. 
All subjects gave oral or written, informed consent to the 
study, which was conducted in accordance with the declara- 
tions of Helsinki and Tokyo. 
Eehocardiography. The M-mode echocardiographic study 
of the left ventricle was performed under two-dimensional 
echocardiographic control with the use of commercially avail- 
able machines. All measurements were made at end-expiration 
at the onset of the QRS complex using the American Society of 
Echocardiography leading edge to leading edge criteria ac- 
cording to standard laboratory procedures described previ- 
ously (8,9). Only tracings with optimal visualization of inter- 
faces and showing simultaneous visualization of the septum, 
left ventricular internal diameter and posterior wall were 
considered adequate to determine l ft ventricular mass. Echo- 
cardiographic examinations were performed by two physicians 
(P.V., G.S.), and the tracings were read by two other investi- 
gators. The mean value from at least five measurements of the 
left ventricle per observer was computed. At the time of the 
echocardiographic examination, all involved investigators were 
unaware of patients' casual and ambulatory blood pressure 
values. 
Left ventricular mass in grams was calculated by the formula 
introduced by Devereux et al. (10): 0.80 × (1.04 × [(Septal 
thickness + Left ventricular internal diameter + Posterior wall 
thickness) 3 - (Left ventricular internal diameter)3]) + 0.6 g 
and normalized by body surface area. A normal left ventricular 
mass was defined as a mass <125 g/m 2 in both men and 
women. This partition value has been used in some prospective 
studies (1,2,4) of the independent prognostic value of echocar- 
diographic left ventricular hypertrophy, two of which (2,4) 
were performed ina mixed study group of men and women. A 
dividing line between absence and presence of left ventricular 
hypertrophy atechocardiography may also be drawn by using 
gender-specific height-adjusted values of left ventricular mass, 
as done in the Framingham Heart Study (3), or by using values 
of left ventricular mass normalized by height elevated by a 
power of 2.7, as recently suggested by de Simone t al. (11). A 
Cornell voltage score >2.0 mV in women or >2.8 mV in men 
(12) defined left ventricular hypertrophy by standard 12-lead 
electrocardiography. 
The two-dimensional echocardiographic study showed sym- 
metric left ventricular contraction i all subjects; hence, left 
ventricular volumes were calculated from end-diastolic and 
end-systolic diameters by using the Teichholz formula (13), 
which proved accurate inthe absence of regional abnormalities 
of contraction (14). Stroke volume (End-diastolic - End- 
systolic volume) and cardiac output (Stroke volume × Instan- 
taneous heart rate) were subsequently normalized by body 
surface area to obtain stroke index and cardiac index. Total 
peripheral resistance was derived as (Mean blood pressure × 
80)/Cardiac output, where mean blood pressure was calculated 
as [Diastolic blood pressure + (Systolic blood pressure - 
Diastolic blood pressure)/3]. Blood pressure was measured 
during the echocardiographic examination by a standard mer- 
cury sphygmomanometer. End-systolic meridional wall stress 
was calculated by using the formula introduced and validated 
by Reicbek et al. (15). 
Endocardialfractional shortening, defined as [(End-diastolic 
diameter - End-systolic diameter)/End-diastolic diameter] × 
100, was calculated according to Lutas et al. (16) as observed 
value and as a percent of the predicted value on the basis of the 
regression equation between meridional end-systolic stress and 
fractional shortening in a normotensive group of 121 subjects 
(6). 
Midwall fractional shortening was estimated by taking into 
account he migration toward the epicardium of midwall eft 
ventricular fibers from end-diastole to end-systole; it was 
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expressed as observed value and as percent of predicted value 
according to the method reported by de Simone et al. (17). 
Definition of groups. All patients examined in this study 
had a normal eft ventricular mass (<125 g/m2). They were 
classified into two groups: normal eft ventricular geometry 
and left ventricular concentric remodeling, the latter defined 
by the thickness of the septum or posterior wall divided by left 
ventricular radius ->0.45. This partition value has been previ- 
ously reported in cross-sectional (5) and prospective (2) stud- 
ies of the clinical significance of the different patterns of left 
ventricular adaptation to hypertension. We (6) recently pro- 
posed extending the use of this cutoff point to define patterns 
of isolated relative thickening of the interventricular septum, 
because this condition was associated with features uggesting 
increased cardiovascular risk. 
Ambulatory blood pressure monitoring. Ambulatory blood 
pressure was recorded by using the SpaceLabs units 5200, 
90202 and 90207 set to take a measurement every 15 min for 
24 h. Reading, automated iting and analysis of data provided 
by the recorders were done by the ABP5600, ABP90204 and 
ABP90209 interfaces (SpaceLabs). Systolic readings >260 or 
<70 mm Hg, diastolic readings >150 or <40 mm Hg and pulse 
pressure readings >150 or <20 mm Hg were automatically 
discarded. The daytime period was defined as the time interval 
between 6 AM and 10 PM, and the nighttime period as that 
between 10 PM and 6 AM. The spontaneous day to day 
variability of 24-h, daytime and nighttime ambulatory blood 
pressure has previously been assessed insome of these patients 
(18). 
Clinical follow-up. After their initial diagnostic studies, all 
patients included in the PIUMA registry were followed up in 
the outpatient clinic of the referring hospital or by their family 
doctors and were treated with standard life-style and pharma- 
cologic measures intended to reduce clinic blood pressure to 
<140/90 mm Hg. The PIUMA protocol recommends that, in 
the absence of universally established normative values on 
ambulatory blood pressure measures, therapeutic strategies 
should be based on clinic blood pressure. Ambulatory blood 
pressure data remained accessible to patients and their doctors 
but were unlikely to significantly influence therapeutic deci- 
sions because they were generally considered to be investiga- 
tional findings of unproved clinical utility. Diuretic drugs, 
beta-adrenergic blocking agents, angiotensin-converting en-
zyme inhibitors, calcium channel blockers and alphal-blockers, 
alone or in various combinations, were the antihypertensive 
drugs most frequently used. 
Evaluation of cardiovascular events. Telephone interviews 
were conducted to ascertain the incidence of major complica- 
tions of hypertension. All interviews were conducted irectly 
with the patient without knowledge of results of echocardiog- 
raphy and ambulatory blood pressure monitoring; they were 
followed by a clinical visit whenever the patient consented. 
Hospital record forms of patients who developed acardiovas- 
cular event were reviewed in conference by the authors of this 
study. 
The following definitions were used. Cardiovascular events 
included myocardial infarction, stroke, sudden death, angina 
pectoris, coronary revascularization, transient cerebral isch- 
emic attack, aortoiliac occlusive disease, documented throm- 
botic occlusion of a retinal artery, progressive cardiac or renal 
failure. Myocardial infarction was diagnosed on the basis of at 
least two of three standard criteria (typical chest pain, ECG 
QRS changes [both Q wave and non-Q wave infarctions were 
considered], transient elevation of serum myocardial enzymes 
by more than twice the upper normal laboratory limits). 
Angina pectoris was defined by chest pain accompanied by 
typical ischemic hanges on the ECG (1 mm of horizontal or 
downsloping ST segment depression during exercise testing in 
the absence of digoxin and without ST depression at rest, 1 mm 
of horizontal or downsloping ST depression lasting ->1 rain 
during Holter ambulatory ECG monitoring). Sudden death was 
defined as a witnessed eath that occurred within 1 h after the 
onset of acute symptoms, with no history that violence or 
accident played any role in the fatal outcome. Stroke was 
diagnosed on the basis of rapid onset of localizing neurologic 
deficit lasting ->24 h in the absence of any other disease 
process explaining the symptoms. Transient ischemic attack was 
defined by the diagnosis, made by a physician, of any sudden 
focal neurologic deficit that cleared completely in <24 h. 
Statistical analysis. We compared the two hypertensive 
groups (concentric remodeling and normal left ventricular 
geometry) in terms of cardiovascular morbidity expressed as 
the combined number of fatal plus nonfatal cardiovascular 
events over the follow-up period. Event rates are presented as 
the number of events per 100 patient-years based on the ratio 
of the observed number of events to the total number of 
patient-years of exposure. For the subjects who experienced 
multiple nonfatal events, the analysis included only the first 
event. 
Survival curves were estimated using Kaplan-Meier (19) 
product limit method, and compared by the Mantel (20) 
(log-rank) test. The effect of prognostic factors on survival was 
evaluated by Cox semiparametric egression models (21). The 
assumption of proportional hazard over time was verified 
before performing the analysis and was met by all covariates. 
The covariates included in the Cox models were age (<40 
years, 40 to 60 years, >60 years), gender (female, male), 
diabetes (no, yes), mean office blood pressure, mean 24-h 
ambulatory blood pressure, left ventricular mass index and 
geometry (normal eft ventricular geometry, concentric left 
ventricular remodeling). The assumption concerning risk lin- 
earity for office and ambulatory blood pressure was verified by 
visual inspection. Age was analyzed as a categoric variable 
because of the abrupt increase of risk after age 60 years, with 
consequent failure to pass a linearity test. Adjusted relative 
risks for the significant Cox model factors were calculated as 
the antilogarithm of the b i coefficient (exp bi). Ninety-five 
percent confidence intervals around the estimates of relative 
risk were obtained from the formula exp[b i _+ (1.96 × SE bi)], 
where SE is the standard error of b i. 
The other comparisons between the groups were made by 
Student  test and chi-square test when appropriate. In two- 
874 VERDECCHIA ET AL. JACC Vol. 25, No. 4 
LEFt  VENTRICULAR REMODELING IN HYPERTENSION March 15, 1995:871-8 
Table 1. Clinical Characteristics and Indexes of Disease Severity in Hypertensive Patients 
Hypertensive Patients 
Normal LV Concentric LV 
All Geometry Remodeling 
(n - 694) (n = 422) (n - 272) 
Male (% patients) 44% 42% 47% 
Known duration of hypertension (yr) 4.4 ± 5.8 3.8 + 5.2 5.1 ~ 6.7* 
Never treated for hypertension (% patients) 71.8% 76.8% 64.0%* 
Age (yr) 50 -+ 12 49 + 12 52 ± 11' 
Height (cm) 166 _+ 9 166 _+ 9 166 ~+ 8 
Body weight (kg) 73 _+ 14 73 + 13 73 ± 13 
Body surface area (m 2) 1.81 + 0.19 1,80 _+ 0.19 1.81 ~ 0.19 
Body mass index (k&'m 2) 26.3 + 4 26.2 + 4 26.5 ~+ 4 
ONce BP (mm Hg) 
Systolic 155 + 17 153 + 16 158 + 19' 
Diastolic 96 +_ 9 95 _+ 9 98 ± 10" 
ONce HR (beats/rain) 75 + 10 74 + 10 76 + 11 
Average ambulatory, BP (mm Hg) 
24-h systolic 135 + 13 132 ± 13 139 + 14' 
24-h diastolic 86 + 9 84 _+ 9 88 + 9* 
Daytime systolic 140 + 14 137 -- 13 145 + 14" 
Daytime diastolic 90 ± 9 89 +_ 9 93 ± 9* 
Nighttime systolic 125 + 15 123 = 15 130 + 16" 
Nighttime diastolic 77 ± 11 76 _+ 10 79 ± 11" 
BP fall from day to night (%) 
Systolic 11.3 _+ 7% 11.6 _+ 7% 10.9 ± 6% 
Diastolic 15.9 + 7% 16.1 _+ 8% 15.7 + 7% 
Average ambulatory HR (beats/rain) 
24-h 75 _+ 9 75 _+ 9 76 ~+ 9 
Daytime 79 - 10 79 _+ 10 80 2 9 
Nighttime 68 ± 9 67 _+ 9 68 ± 9 
Funduscopic grade (% patients) 
-<I 94% 94% 94% 
->II 6% 6% 6% 
Serum glucose (mg/dl) 99 ± 19 98 ± 18 101 ± 21 
Serum creatinine (mg/dl) 0.95 -+ 0.25 0.93 -+ 0.19 0.97 ± 0.31 
Serum cholesterol (mN,'dl) 
Total 212 + 42 212 + 42 212 -+ 41 
HDL 49 + 12 49 + 12 49 -+ 13 
LDL 136 + 38 137 + 38 135 ± 38 
Serum triglycerides (mg/dl) 146 + 96 138 + 89 157 ± 107t 
*p < 0.01, +p < 0.05 versus patients with left ventricular normal geometry,. Unless otherwise indicated, data are 
expressed as mean value -+ SD. BP = blood pressure; HDL high densi~' lipoprotein; HR = heart rate; LDL = low 
density lipoprotein; LV - left ventricular. 
tailed tests, p values <0.05 were considered statistically signif- 
icant. SAS statistical software, version 6.08, was used to 
perform analysis. 
Resu l t s  
Clinical characteristics. Some clinical characteristics and 
indexes of disease severity in the overall population and in the 
two groups with normal left ventricular geometry and concen- 
tric left ventricular remodeling are reported in Table 1. 
Prevalence of concentric remodeling was 39.2%. There were 
no differences in gender, height, weight, body surface area and 
body mass index between the two patient subsets. In contrast, 
patients with concentric remodeling were slightly older, had a 
longer duration of hypertension and a more frequent history of 
previous use of antihypertensive drugs (36.0% vs. 23.2%, p < 
0.01). 
Baseline office blood pressure and ambulatory blood pressure 
during the day and at night were definitely higher in the group 
with concentric left ventricular remodeling (all p < 0.01). The 
distribution of funduscopic changes and serum levels of glu- 
cose, creatinine and total, and high and low density lipoprotein 
cholesterol did not differ between the two groups. Serum 
triglycerides were slightly higher in the group with concentric 
remodeling (p < 0.05). 
During follow-up, 59% of patients with normal left ventric- 
ular geometry were being treated with life-style measures 
alone, as opposed to 42% of patients with concentric left 
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Table 2. Echocardiographic Measures ofLeft Ventricular Structure and Function in 
Hypertensive Patients 
Hypertensive Patients 
All Normal LV Concentric LV 
Patients Geometry Remodeling 
Interventricular septal thickness (cm) 
End-diastole 1.03 _+ 0.20 0.92 + 0.15 1.21 +_ 0.14" 
End-systole 1.52 + 0.24 1.45 _+ 0.22 1.65 + 0.21' 
Left ventricular internal diameter (cm) 
End-diastole 4.90 + 0.52 5.11 _+ 0.48 4.56 + 0.38* 
End-systole 3,04 + 0.48 3.18 _+ 0.47 2.81 _+ 0.40* 
Posterior wall thickness (cm) 
End-diastole 0,90 + 0.16 0.84 + 0.14 1.00 _+ 0.13" 
End-systole 1,63 _+ 0.23 1.59 _+ 0.23 1.69 _+ 0.23* 
Left ventricular mass 
g 169 _+ 39 162 _+ 40 18l _+ 33* 
g,/m 2 93 _+ 18 89 -+ 18 100 + 15" 
g]m 102 -+ 22 97 _+ 22 109 + 18" 
g/m 27 43.0 + 9 40.9 -+ 9 46.2 _+ 8* 
Endocardial fractional shortening (%) 
Observed 38.1 + 7 37.8 + 7 38.4 _+ 7 
Percent of predicted 107 -+ 13 110 + 13 101 -+ 12" 
Midwall fractional shortening (%) 
Observed 17.7 _+ 3 19.1 _+ 3 15.5 _+ 2* 
Percent of predicted 98.5 + 19 107.7 _+ 17 84.2 + 11" 
End-systolic wall stress (103 dynes/cm 2) 65 + 22 71 -+ 22 57 + 18' 
Cardiac index (liters/rain per m 2) 3.192 + 0.9 3.476 -+ 0.9 2.752 _+ 0.7* 
Total peripheral resistance (dynes. s. cm 5) 1,730 _+ 510 1,556 _+ 410 2,008 _+ 516" 
*p < 0.01 versus patients with normal eft ventricular geometry. All data are expressed as mean value -+ SD. LV = 
left ventricular. 
ventricular remodeling (p < 0.01). In contrast, he distribution 
of beta-blockers and diuretics, alone or combined, that of 
calcium channel blockers or angiotensin-converting enzyme 
inhibitors, alone or combined, and that of different drug 
combinations did not show any significant difference between 
the two groups (10%, 18% and 13%, respectively, in those with 
normal eft ventricular geometry vs. 11%, 26% and 21% in 
those with concentric remodeling). 
Left ventricular structure and function. Left ventricular 
mass, before and after indexing for body surface area, height or 
height elevated at the power of 2.7 (11), was greater in the 
subset with concentric left ventricular remodeling than in that 
with normal ventricular geometry (Table 2). Interventricular 
septum thickness and posterior wall thickness at end-diastole 
and end-systole were greater in the group with concentric 
remodeling (all p < 0.01), whereas end-diastolic and end- 
systolic diameters were greater in the group with normal 
geometry (both p < 0.01). Endocardial fractional shortening 
did not differ between the groups, whereas midwall fractional 
shortening was depressed in the group with concentric remod- 
eling (p < 0.01). The ratios of observed to predicted endocar- 
dial and midwall fractional shortening were lower in the group 
with concentric remodeling than in the group with normal 
ventricular geometry (all p < 0.01). Total peripheral resistance 
was increased and cardiac index decreased in the subset with 
concentric remodeling (all p < 0.01). Meridional end-systolic 
wall stress was greater in the subset with normal ventricular 
geometry (p < 0.01). In 3.3% of subjects the Cornell voltage 
(R wave in lead aVE + S wave in lead V3) (12) was increased 
(>2.0 mV in women or >2.8 mV in men). 
Cardiovascular morbidity. We obtained complete follow-up 
data from 686 (98.8%) of the 694 subjects who entered the study. 
The mean duration of follow-up was 2.71 years (range 0.1 to 7.7). 
We documented 29 cardiovascular events (6 fatal and 23 
nonfatal). In the group with normal left ventricular geometry, 
there were three patients with stroke, three with myocardial 
infarction, two with sudden cardiac death, three with transient 
ischemic attacks, one with coronary revascularization a d two 
with occlusive peripheral vascular disease. In the group with 
concentric left ventricular remodeling there were four patients 
with stroke, two with myocardial infarction, one with sudden 
cardiac death, two with transient ischemic attacks, one with 
coronary revascularization, one with angina, one with new- 
onset heart failure, two with occlusive peripheral vascular 
disease and one with progressive renal failure requiring dialy- 
sis. Overall, the distribution of antihypertensive treatments 
did not differ between the patients who did or did not have 
a cardiovascular morbid event. Thus, life-style measures; 
beta-blockers or diuretic drugs (alone or in combination); 
angiotensin-converting e zyme inhibitors (alone or in combi- 
nation); or different drug combinations were used in 52%, 
10%, 21% and 17%, respectively, of patients with an event 
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Table 3. Event Rates According to Geometric Patterns of the Left Ventricle in Hypertensive Patients 
Hypertensive Patients 
All Normal LV Concentric LV 
Patients Geometry Remodeling 
(n = 694) (n = 422) (n = 272) 
Duration of follow-up (yr) 
Cardiovascular events (no.) 
Rate of events (× 100 patient-years) 
2.72 2.94 2.35 
29 14 15 
1.53 1.12 2.34 
LV = left ventricular. 
versus 45%, 17%, 24% and 14% of those without events (p = 
0.58). 
Cardiovascular morbidity, expressed as the combined num- 
ber of fatal and nonfatal events per 100 patient-years (Table 3), 
was 1.53 in the overall study group, 1.12 in the group with 
normal eft ventricular geometry and 2.39 in that with concen- 
tric left ventricular remodeling (Fig. 1, left panel). Event-free 
survival curves (Fig. 1, right panel) differed between the two 
groups (p = 0.024, log-rank test). After assessment of the 
independent association with several covariates (age, gender, 
diabetes, left ventricular mass index, mean clinic blood pres- 
sure and mean 24-h ambulatory blood pressure) in Cox 
proportional hazard models, the risk of cardiovascular morbid 
events {Table 4) was higher in the group with concentric 
remodeling than in that with normal geometry (relative risk 
2.56; 95% confidence interval 1.20 to 5.45; p < 0.01). 
Figure 1. Incidence ofcardiovascular morbid events in the subset with 
normal eft ventricular geometry, and in that with concentric left 
ventricular remodeling (left panel) and event-free survival curves in 
the two subsets (right panel). Data refer to 694 subjects with essential 
hypertension a d left ventricular mass < 125 g/m 2 on echocardiography 
who were followed up for -<7.7 years. 
Discuss ion  
Previous reports have suggested that echocardiography 
plays an important role in cardiovascular risk stratification i
essential hypertension. For any given value of blood pressure 
and other risk factors for cardiovascular disease, cardiovascu- 
lar morbidity and mortality are less in hypertensive patients 
with normal eft ventricular mass on echocardiography t an in 
those with left vcntricular hypertrophy (1,2). The Framingham 
Heart Study (3) clearly demonstrated the independent prog- 
nostic significance of echocardiographic leftventricular mass in 
a large general population sample. The new finding in the 
present study is that even in the presence of a normal left 
ventricular mass, the echocardiographic definition of left ven- 
tricular geometry (i.e., normal geometry vs. concentric remod- 
eling) provides a further independent s ratification of cardio- 
vascular risk in relatively healthy unselected patients with 
essential hypertension. Cardiovascular morbidity was consis- 
tently higher in the group with concentric remodeling than in 
that with normal ventricular geometry, and the prognostic 
value of this categorization persisted after assessment of the 
independent effect of several covariates including age, gender, 
diabetes, left ventricular mass index, clinic blood pressure and 
average 24-h ambulatory blood pressure. 
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Table 4. Relative Risks for Cardiovascular Morbid Events in 694 
Patients With Essential Hypertension a d Normal Left Ventricular 
Mass Who Were Followed Up for <7.7 Years 
Relative Risk 
Covariates (95% CI) p Value 
2.56 (1.20-5.45) <0.01 Left ventricular geometric pattern on 
echocardiography: concentric remodeling 
vs. normal geometry 
Age 
>60 yr vs. <40 yr 
40-60 yr vs. <40 yr 
Gender (men vs. women) 
Diabetes (present vs. absent) 
15.20 (2.04-113.41) <0.008 
4.57 (0.5-35.16) 0.14 
4.86 (2.11-11.18) <0.0002 
3.38 (1.51-7.58) <0.003 
cI = confidence interval. 
Prognostic significance of left ventricular remodeling in 
hypertension. In a 10-year observational study in hypertensive 
patients, Koren et al. (2) found a rate of cardiovascular morbid 
events of 1.8/100 patient-years in 150 patients with normal left 
ventricular geometry and of 4.2/100 patient-years in 34 patients 
with concentric left ventricular remodeling. However, the small 
sample size precluded a multivariate assessment of the prog- 
nostic significance of left ventricular geometric patterns in the 
subgroup with normal ventricular mass (2). The present study 
confirms and extends those findings to a larger patient group 
with essential hypertension a d normal left ventricular mass at 
echocardiography (422 patients with normal ventricular geom- 
etry and 272 patients with concentric remodeling), all of whom 
were untreated atthe time of their initial diagnostic evaluation. 
Although the duration of follow-up was shorter in our study 
than in that of Koren et al. (2), our sample size was adequate 
to detect prognostic differences between the subgroup with 
normal ventricular geometry and that with concentric ventric- 
ular remodeling. The difference in cardiovascular morbidity 
between the two groups remained statistically significant after 
adjustment for several covariates, including average 24-h am- 
bulatory blood pressure, ameasure of blood pressure currently 
held superior to clinic blood pressure in predicting target organ 
damage (8,22) and future cardiovascular complications (7,23- 
26) of hypertension. At variance with Koren et al. (2), who 
defined concentric left ventricular remodeling solely on the 
basis of relative thickening of the posterior wall, we separated 
patients with isolated relative thickening of the interventricular 
septum from those with normal eft ventricular geometry and 
included these patients in the group with ventricular remodel- 
ing. Using the Cornell definition of relative wall thickness 
reported by Koren et al. (2), we calculated the prevalence of 
the different patterns of left ventricular geometry inour overall 
hypertensive group, including 240 subjects with left ventricular 
mass >125 g/m 2, and found a 61% prevalence (570 subjects) of 
normal left ventricular geometry, a 13.3% prevalence (124 
subjects) of concentric left ventricular remodeling, a 14.3% 
prevalence of eccentric left ventricular hypertrophy and an 
11.3% prevalence of concentric left ventricular hypertrophy. 
Corresponding figures in the study of Koren et al. (2) were 
similar (59.3%, 13.4%, 15.8% and 11.5%, respectively). Even 
the prevalence of left ventricular hypertrophy was comparable 
in our overall hypertensive group (26%) and in the Cornell 
series (27%) (2). As assessed by using the Cornell definition of 
relative wall thickness (2), the rate of cardiovascular morbid 
events in our group with normal left ventficular geometry was 
1.5/100 patients per year, vs. 1.6/100 patients per year in the 
group with concentric remodeling (log-rank test: p = 0.062). 
Thus, by moving persons at slightly increased risk from the 
group with normal geometry to that with concentric remodel- 
ing, the present definition of concentric remodeling may have 
improved cardiovascular risk stratification i hypertensive sub- 
jects with normal eft ventricular mass. A previous tudy from 
our laboratory showed that asymmetric ventricular remodeling 
due to isolated septal thickening in hypertensive subjects with 
normal ventricular mass was associated with a greater clinic 
and ambulatory blood pressure and left ventricular mass, and 
other features uggested an increased cardiovascular risk in 
these subjects (6). 
Patients with concentric left ventricular emodeling were 
older and had a longer known duration of hypertension, an 
increased clinic and ambulatory blood pressure and slightly 
higher levels of serum triglycerides than did the patients with 
normal ventricular geometry. On echocardiography, they had 
greater septal and posterior wall thickness, smaller internal 
diameter, greater left ventricular mass and a depressed con- 
tractile performance as assessed by using either the midwall 
fractional shortening or the ratio of observed to predicted 
fractional shortening, both endocardial nd midwall. In addi- 
tion, they had a decrease in cardiac index with increased total 
peripheral resistance despite reduced end-systolic stress. The 
reliability of left ventricular volumes calculated by using 
the Teichholz formula may be limited in our conditions by the 
different minor/major left ventricular axis relation in the two 
groups. However, all these findings concur in showing that 
concentric left ventricular remodeling is an important echocar- 
diographic finding that should be searched for and considered 
as a marker of increased cardiovascular risk in hypertensive 
patients with normal eft ventricular mass. We rule out the 
possibility that the use of 125 g/m 2 as a partition value between 
normal ventricular mass and ventricular hypertrophy in both 
men and women may have produced the inclusion of a 
significant number of women with left ventricular hypertrophy 
based on gender-specific criteria into the group with concentric 
remodeling. In fact, there were only 33 women with left 
ventricular mass between 110 g/m 2 (27) and 125 g/m 2 (and only 
one event among them) in the group of 143 women (with six 
events) with concentric remodeling. 
The mechanisms by which concentric left ventricular re- 
modeling may predispose patients without echocardiographic 
left ventricular hypertrophy to cardiovascular morbid events 
cannot be assumed from our study. The excess risk associated 
with concentric left ventricular remodeling persisted over time 
despite standard antihypertensive therapy. More patients with 
normal left ventricular geometry than with concentric left 
ventricular remodeling received nonpharmacologic measures, 
but the distribution of the various classes of antihypertensive 
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drugs in those who received therapy did not differ between 
these two groups or between the subjects who experienced an 
event and those who did not. The low event rate in our patient 
group (1.53 events/100 patient-years) and the relatively low 
duration of follow-up were compatible with a modest predicted 
effect on outcome by antihypertensive therapy, as suggested by 
results of large trials in mild hypertension (28,29). 
It is tempting to speculate that concentric left ventricular 
remodeling might represent a distinct entity of an early stage of 
development of left ventricular hypertrophy, as suggested for 
example by the findings of increased left ventricular mass, 
duration of hypertension a d age in these subjects. 
Conclusions. From this study we conclude that concentric 
remodeling ofthe left ventricle, defined by the thickness of the 
septum or posterior wall divided by the left ventricular radius 
at end-diastole >-0.45, is an important independent predictor 
of increased cardiovascular risk in hypertensive subjects with 
normal (<125 g/m e) left ventricular mass. Additional studies 
are needed to determine whether effective antihypertensive 
treatment may be accompanied by restoration ofa normal left 
ventricular geometric pattern and whether this effect may have 
implications for cardiac function and prognosis. Further re- 
search issues are the clinical feasibility and etficacy of more 
intensive use of life-style measures and deferral of drug 
treatment over time in hypertensive subjects with normal eft 
ventricular geometry on echocardiography who have no other 
cardiovascular risk factors. 
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